Invention Grant
US08716252B2 (Methylsulfonyl) ethyl benzene isoindoline derivatives and their pharmaceutical uses
有权
（甲基磺酰基）乙基苯异吲哚啉衍生物及其药物用途
- Patent Title: (Methylsulfonyl) ethyl benzene isoindoline derivatives and their pharmaceutical uses
- Patent Title (中): （甲基磺酰基）乙基苯异吲哚啉衍生物及其药物用途
-
Application No.: US13518843Application Date: 2010-12-21
-
Publication No.: US08716252B2Publication Date: 2014-05-06
- Inventor: Peter H. Schafer , Anthony J. Frank , Hon-Wah Man , Sai L. Shankar
- Applicant: Peter H. Schafer , Anthony J. Frank , Hon-Wah Man , Sai L. Shankar
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- International Application: PCT/US2010/061420 WO 20101221
- International Announcement: WO2011/079091 WO 20110630
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A61K31/40 ; C07H17/02 ; C07D209/46
Abstract:
Provided are (methylsulfonyl)ethyl benzene isoindoline compounds, and pharmaceutically acceptable salts, solvates, or stereoisomers thereof. Methods of use and pharmaceutical compositions of these compounds are also disclosed.
Public/Granted literature
- US20130116204A1 (METHYLSULFONYL) ETHYL BENZENE ISOINDOLINE DERIVATIVES AND THEIR PHARMACEUTICAL USES Public/Granted day:2013-05-09
Information query
